TrialCancer medicine2020

A double-blind, randomized, multicenter phase 3 study of palonosetron vs granisetron combined with dexamethasone and fosaprepitant to prevent chemotherapy-induced nausea and vomiting in patients with breast cancer receiving anthracycline and cyclophosphamide.

Koji Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.